Is Sakar Healthcare Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Sakar Healthcare Ltd (SAKAR.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Sakar Healthcare Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sakar Healthcare Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Sakar Healthcare Ltd?

Muslim investors may consider investing in Sakar Healthcare Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Sakar Healthcare Ltd classified as HALAL?

Musaffa determines the Shariah status of Sakar Healthcare Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Sakar Healthcare Ltd updated?

The Shariah compliance status of Sakar Healthcare Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Sakar Healthcare Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Sakar Healthcare Ltd?

You can check the latest Shariah compliance status of Sakar Healthcare Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Sakar Healthcare Ltd SAKAR.NS

₹696.70 ₹96.90 (16.16%) 1D

Last Updated: May 15, 12:00 AM·NSE

SAKAR.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 06, 2026

Report Source: 2026 3rd Quarter Report

Sakar Healthcare Ltd. Stock Analysis SAKAR.NS

India Health Care Micro Cap Report: Q3, 2026

Sakar Healthcare Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat and currently employs 342 full-time employees. The company went IPO on 2016-10-14. The firm is engaged in manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectables (SVP) in ampoules and vials & lyophilized injections. The firm's oncology products include oral solid dosage (tablet & capsule), liquid injection, lyophilized injection, active pharmaceutical ingredient (API), CDMO products and CRAMs. The company has a presence across the regions of Africa (Anglo & Francophone), SEASIA, CIS, Latin & Central America and in Europe. The company operates in over 50 countries globally and has approximately 292 registered products. The company exports to Southeast Asia, Asia, Africa-Anglo & Francophone, MENA, America, covering around 38 countries with more than 250 brands registered.

Key Statistics of Sakar Healthcare Ltd (SAKAR.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹586.70₹709.70

Today's Open

₹599.80

Volume

1.17M

P/E Ratio (TTM)

71.44

52 Week Range

₹300.00₹709.70

Market Cap

14.32B

Avg. Volume

162.17K

Dividend Yield

Financial Metrics & Statements of Sakar Healthcare Ltd (SAKAR.NS)

FAQ's for Sakar Healthcare Ltd (SAKAR.NS)

According to Musaffa’s Shariah screening methodology, Sakar Healthcare Ltd (SAKAR.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.